Seres Therapeutics (MCRB) Exchange Rate Effect (2021 - 2024)
Seres Therapeutics (MCRB) posted Exchange Rate Effect of -$1000.0 for Q4 2024, down 200.0% sequentially from $1000.0 in Q3 2023.
Seres Therapeutics (MCRB) Exchange Rate Effect (2021 - 2024) Analysis & Trends
Seres Therapeutics has reported Exchange Rate Effect for 4 years, with the latest figure at -$1000.0 in Q4 2024.
- Quarterly Exchange Rate Effect changed N/A year-over-year to -$1000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2024 was $2000.0 (up 300.0% YoY) and the FY2024 annual result came in at -$1000.0, down 150.0% from the prior year.
- Exchange Rate Effect slipped to -$1000.0 in Q4 2024 per MCRB's latest filing, from $1000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $1000.0 in Q4 2022 and troughed at -$2000.0 in Q3 2022.
- A 4-year average of -$400.0 and a median of -$1000.0 in 2021 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect jumped 200.0% in 2022, then surged 150.0% in 2023.
- Over 4 years, Exchange Rate Effect stood at -$1000.0 in 2021, then surged by 200.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then slumped by 200.0% to -$1000.0 in 2024.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1000.0, $1000.0, and $1000.0 for Q4 2024, Q3 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |